Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
marco.salvetti@uniroma1.it
Marco Salvetti
Professore Ordinario
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
marco.salvetti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience
NEUROTHERAPEUTICS
2024
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach
MULTIPLE SCLEROSIS
2024
Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report
NEUROLOGICAL SCIENCES
2024
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN)
NEUROLOGICAL SCIENCES
2024
Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease
FRONTIERS IN NEUROLOGY
2024
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study
JOURNAL OF NEUROLOGY
2024
EBV infection drives MS pathology: Yes
MULTIPLE SCLEROSIS
2024
Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis
MICROORGANISMS
2024
Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy
PATHOGENS
2024
Exploring miRNAs' based modeling approach for predicting PIRA in multiple sclerosis. A comprehensive analysis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024
Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7
THE CEREBELLUM
2024
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program
MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL
2024
Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Sars-CoV2 infection in pregnant women with multiple sclerosis
MULTIPLE SCLEROSIS
2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?
EUROPEAN JOURNAL OF NEUROLOGY
2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observation
MULTIPLE SCLEROSIS AND RELATED DISORDERS
2023
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients
NEUROLOGICAL SCIENCES
2023
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO)
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
2023
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
FRONTIERS IN IMMUNOLOGY
2023
1
2
3
4
5
6
7
8
9
seguente ›
ultima »
Progetti di Ricerca
Looking for final effectors of regulome alterations in MS: LMP1-mediated dysregulation of AID in MS pathogenesis
Epstein-Barr virus genotypes in multiple sclerosis
Impact of genetic and non-genetic risk factors for MS on regulatory RNAs.
Laboratori di ricerca
Laboratori di Colture Cellulari 2
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma